ap

Skip to content
Health | Denver Health’s opioid monitoring program…
Sunday, August 30th 2026

Trending:

Breaking News

News
Health

Denver Health’s opioid monitoring program snared in controversy over past links to Purdue Pharma

FDA wants more information, while advocacy groups say RADARS program has too many drugmaker ties

The U.S. Food and Drug Administration campus in Silver Spring, Md., is photographed on Oct. 14, 2015. The agency's plan to study a survey of people seeking drug treatment kicked up a controversy around a drug research program based at Denver Health. (AP Photo/Andrew Harnik, File)
The U.S. Food and Drug Administration campus in Silver Spring, Md., is photographed on Oct. 14, 2015. The agency’s plan to study a survey of people seeking drug treatment kicked up a controversy around a drug research program based at Denver Health. (AP Photo/Andrew Harnik, File)
DENVER, CO - MARCH 7: Meg Wingerter - Staff portraits at the Denver Post studio. (Photo by Eric Lutzens/The Denver Post)
By | mwingerter@denverpost.com | The Denver Post
PUBLISHED:
Getting your player ready...
A drug research program at Denver Health has landed in the center of a national controversy, with supporters saying it does vital work to understand the landscape of addiction and opponents accusing the program’s staff of helping opioid makers shift blame from their products.
Already have an account? Log In
This article is only available to subscribers
Labor Day Sale

Standard Digital

$2 for 2 years
Offer valid for non-subscribers only

More in Health